Phase 3 trial of selpercatinib in advanced RET-mutant medullary thyroid cancer Journal Article
| Authors: | Hadoux, J.; Elisei, R.; Brose, M. S.; Hoff, A. O.; Robinson, B. G.; Gao, M.; Jarzab, B.; Isaev, P.; Kopeckova, K.; Wadsley, J.; Fohrer, D.; Keam, B.; Bardet, S.; Sherman, E. J.; Tahara, M.; Hu, M. I.; Singh, R.; Lin, Y.; Soldatenkova, V.; Wright, J.; Lin, B.; Maeda, P.; Capdevila, J.; Wirth, L. J.; for the LIBRETTO-531 Trial Investigators |
| Article Title: | Phase 3 trial of selpercatinib in advanced RET-mutant medullary thyroid cancer |
| Journal Title: | New England Journal of Medicine |
| Volume: | 389 |
| Issue: | 20 |
| ISSN: | 0028-4793 |
| Publisher: | Massachusetts Medical Society |
| Date Published: | 2023-11-16 |
| Start Page: | 1851 |
| End Page: | 1861 |
| Language: | English |
| DOI: | 10.1056/NEJMoa2309719 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| PUBMED: | 37870969 |
| DOI/URL: | |
| Notes: | Source: Cinahl |
